Ponce School of Medicine-Moffitt Cancer Center partnership (2/2)

描述(由申请人提供)：扩大庞塞医学院-莫菲特癌症中心合作伙伴关系的目标是：1)维护全面的行政基础设施和程序，以对项目和核心进行关键评估，解决问题，保持质量，并为合作伙伴关系的继续扩展制定战略计划，并为合作伙伴关系教职员工的成功职业发展提供支持。2)让PSM和MCC的基础科学家密切合作开展研究项目：这将使PSM的科学家能够接触到经验丰富的癌症研究科学家作为合作者和导师以及先进技术，以促进他们的职业生涯和他们的科学的影响。反过来，MCC的科学家将受益于参与新的研究项目，重点是拉美裔患者癌症的独特生物学。3)建立一个全面的培训渠道，培养一支基础和临床癌症转化研究科学家队伍，以解决波多黎各和美国大陆学术卫生中心教职员工中拉美裔院士短缺的问题。这将培养出了解与拉美裔癌症健康差异有关的问题并有动力进行研究以解决这些差异的科学家。4)进行严格的外展研究，以了解传播癌症相关信息的最有效方式，并扩大纳入这些发现的社区外展计划。这将改善临床研究和生物库的参与，以及由MCC服务的佛罗里达州和波多黎各拉美裔社区的整体健康。5)在PSM扩大三级转诊临床肿瘤学服务，为社区肿瘤学家和肿瘤学研究员提供教育机会，以及患者获得临床试验的机会，以改善波多黎各西南部目前服务不足的人口的癌症护理。6)首次建立波多黎各高质量肿瘤组织库 这将为基础研究科学家提供独特而有价值的资源，使他们能够做出针对拉美裔癌症患者的发现，这将为为这一人群开发生物标记物驱动的个性化药物提供洞察力。

DESCRIPTION (provided by applicant): The objectives to expand the Ponce School of Medicine-Moffitt Cancer Center Partnership are to: 1) Maintain a comprehensive administrative infrastructure and procedures to perform critical evaluations of the projects and cores, solve problems, maintain quality, and strategically plan for continued expansion of the Partnership, and provide support for the development of the successful careers of the Partnership faculty. 2) Bring together in close collaboration basic scientists at PSM and MCC to conduct research projects: this will provide scientists at PSM access to experienced cancer research scientists as collaborators and mentors as well as advanced technologies, to advance their careers and the impact of their science. Reciprocally, the MCC scientists will benefit from becoming involved in new research projects focused on the unique biology of Hispanic patient cancers. 3) Develop a comprehensive training pipeline to produce a cadre of cancer translational research scientists, both basic and clinical, to address the shortage of Hispanic academicians on the faculties of academic health centers in Puerto Rico and the mainland US. This will produce scientists who are knowledgeable about the issues related to Hispanic cancer health disparities and motivated to perform research to address these disparities. 4) Conduct rigorous outreach research to learn the most effective ways of communicating cancer related information, and expand community outreach programs incorporating these discoveries. This will improve participation in clinical research and biobanking, and the overall health of the Hispanic community in Florida served by the MCC and in Puerto Rico. 5) Expand at the PSM tertiary referral clinical oncology services, educational opportunities for community oncologists and oncology fellows, and patient access to clinical trials to improve cancer care for the currently underserved population of Southwest Puerto Rico. 6) Establish for the first time a high quality tumor bank of tissues from Puerto Rican cancer patients that will provide a unique and valuable resource for the basic research scientists to make discoveries that are specific for Hispanic cancer patients that will provide insight for th development of biomarker driven personalized medicine for this population.